Suppr超能文献

Pit-1 阳性多激素分泌垂体大腺瘤伴中枢性甲亢:罕见病例报告及文献复习。

Pleiomorphism plurihormonal Pit-1-positive macroadenoma with central hyperthyroidism: a rare case report and literature review.

机构信息

Department of Endocrinology, translational Research Key Laboratory for Diabetes, The Second Affiliated Hospital (Xinqiao Hospital) of Army Medical University, 183 Xinqiao Zhengjie, Shapingba District, Chongqing, 400037, People's Republic of China.

Department of Pathology, The Second Affiliated Hospital (Xinqiao Hospital) of Army Medical University, Chongqing, People's Republic of China.

出版信息

BMC Endocr Disord. 2022 Dec 21;22(1):325. doi: 10.1186/s12902-022-01220-2.

Abstract

BACKGROUND

Thyrotropin-secreting pituitary neuroendocrine tumors (PitNETs) are rare pituitary adenomas that are occasionally accompanied by hypersecretion of other anterior pituitary hormones, such as growth hormone (GH) and prolactin (PRL). The clinical, biochemical, and pathological characteristics may represent diverse circumstances.

CASE PRESENTATION

In this report, a 33-year-old female diagnosed with a TSH PitNET co-secreting GH presented no obvious clinical symptoms. The main characteristics were elevated thyroid-stimulating hormone (TSH), free tri-iodothyronine (FT3), and free thyroxine (FT4) levels accompanied by slightly elevated GH and insulin-like growth factor-1 (IGF-1) levels. Magnetic resonance imaging (MRI) detected a pituitary macroadenoma (18 × 16 × 16 mm) with cavernous sinus and suprasellar invasion. Immunohistochemistry revealed diffuse positivity for TSH, strong immunoreactivity for GH, and sporadic positivity for PRL. The electron microscope and double immunofluorescence staining confirmed a plurimorphous plurihormonal adenoma producing TSH, GH, and PRL. After preoperative somatostatin receptor ligand (SRL) treatment and transsphenoidal surgery, the patient achieved temporary clinical and biochemical remission. However, 3 months after surgery, the patient was suspected of having Hashimoto's thyroiditis due to higher thyroglobulin antibody (TGAb), thyroid peroxidase antibody (TPOAb), and thyroid receptor antibody (TRAb) and an enlarged thyroid nodule. During follow-up, thyroid function and TSH slowly transformed from transient hyperthyroidism to hypothyroidism. They were maintained in the normal range by L-T4.

CONCLUSION

In the TSH PitNET, the positive immunohistochemistry for TSH, GH, and PRL translated into hormonal overproduction with TSH and GH.

摘要

背景

促甲状腺激素(TSH)分泌型垂体神经内分泌肿瘤(PitNET)是罕见的垂体腺瘤,偶尔伴有其他前叶垂体激素如生长激素(GH)和催乳素(PRL)的过度分泌。其临床、生化和病理特征可能代表不同的情况。

病例介绍

本报告中,一位 33 岁女性被诊断为 TSH 分泌型 PitNET 合并 GH 分泌,无明显临床症状。主要特征是促甲状腺激素(TSH)、游离三碘甲状腺原氨酸(FT3)和游离甲状腺素(FT4)水平升高,同时伴有 GH 和胰岛素样生长因子-1(IGF-1)水平轻度升高。磁共振成像(MRI)发现垂体大腺瘤(18×16×16mm)侵犯海绵窦和鞍上。免疫组化显示 TSH 弥漫阳性,GH 免疫反应强,PRL 偶见阳性。电子显微镜和双重免疫荧光染色证实为产生 TSH、GH 和 PRL 的多形性多激素腺瘤。术前给予生长抑素受体配体(SRL)治疗和经蝶窦手术,患者达到了暂时的临床和生化缓解。然而,术后 3 个月,由于甲状腺球蛋白抗体(TGAb)、甲状腺过氧化物酶抗体(TPOAb)和甲状腺受体抗体(TRAb)升高和甲状腺结节增大,患者被怀疑患有桥本甲状腺炎。在随访过程中,甲状腺功能和 TSH 从短暂性甲亢逐渐转变为甲减,L-T4 维持在正常范围内。

结论

在 TSH PitNET 中,TSH、GH 和 PRL 的免疫组化阳性转化为 TSH 和 GH 的激素过度分泌。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaec/9769035/234947fa459e/12902_2022_1220_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验